Boehringer Wins 1st Bellwether In Conn. Pradaxa Risk Suit
A Connecticut state jury found in favor of Boehringer Ingelheim Pharmaceuticals Inc. on Friday in the first bellwether trial in a consolidated state proceeding over the alleged bleeding risk of its...To view the full article, register now.
Already a subscriber? Click here to view full article